Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Brain white matter changes in CPAP-treated obstructive sleep apnea patients with residual sleepiness.
Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit.
Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis.
Severe articular and musculoskeletal pain: An unexpected side effect of dimethyl-fumarate therapy for multiple sclerosis.
Poster 200 Demyelinating Polyneuropathy Post-Operatively in a Patient with Squamous Cell Carcinoma of the Tongue: A Case Report.
Patients smoking cannabis are risking their health.
Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Diagnostic Utility of Systematic Aquaporin-4 Antibodies Determination in the First Event of Immune-Mediated Optic Neuritis.
Acute Disseminated Encephalomyelitis in an Incarcerated Adolescent Presents as Acute Psychosis: Case Report and Literature Review.
IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo.
Health Utilities for Multiple Sclerosis.
Social Cognition in Multiple Sclerosis: a Meta-Analysis.
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Intravascular lymphoma mimicking multiple sclerosis.
Parametric Probability Distribution Functions for Axon Diameters of Corpus Callosum.
Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
Clinical aspects of symptomatic hyponatremia.
Atypical Features in a Large Turkish Family Affected with Friedreich Ataxia.
Common antibiotic might be effective treatment for MS.
Neurology of Pregnancy: A Case-Oriented Review.
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.
Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives.

Pages